Ron Bentsur
2018 - UroGen Pharma Ltd.
In 2018, Ron Bentsur earned a total compensation of $6M as Former Chief Executive Officer at UroGen Pharma Ltd., a 202% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $334,000 |
|---|---|
| Option Awards | $1,739,588 |
| Salary | $610,200 |
| Other | $3,266,324 |
| Total | $5,950,112 |
Bentsur received $3.3M in other compensation, accounting for 55% of the total pay in 2018.
Bentsur also received $334K in non-equity incentive plan, $1.7M in option awards and $610.2K in salary.
Rankings
In 2018, Ron Bentsur's compensation ranked 1,587th out of 14,244 executives tracked by ExecPay. In other words, Bentsur earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,587 out of 14,244 | 89th |
Division Manufacturing | 558 out of 5,759 | 90th |
Major group Chemicals And Allied Products | 176 out of 2,122 | 92nd |
Industry group Drugs | 139 out of 1,811 | 92nd |
Industry Pharmaceutical Preparations | 102 out of 1,385 | 93rd |
Source: SEC filing on April 26, 2019.
Bentsur's colleagues
We found six more compensation records of executives who worked with Ron Bentsur at UroGen Pharma Ltd. in 2018.
2018
Stephen Mullennix
UroGen Pharma Ltd.
Chief Financial Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.